WeMedals Medical Debuts Interventional Robots, Showcasing Made-in-China Innovation At CIFTIS 2025
The CIFTIS 2025 recently opened with great fanfare at Shougang Park in Beijing. On September 10, President Xi Jinping sent a congratulatory letter to CIFTIS, stating:"China is willing to work with all parties to promote open and innovative cooperation in global services trade, build an open world economy, and continuously inject new impetus into building a community with a shared future for mankind."
At this event of the highest national significance, WeMed Medical had a strong presence, showcasing Endovascular Robotic System in the core exhibition area, delivering keynote speeches, and signing agreements for medical robot leasing projects-highlighting China's latest achievements in self-reliance and the advancement of high-end medical equipment.
By harnessing AI, precision engineering, and remote capabilities, WeMed Medical's Endovascular Robotic System is transforming surgery-enhancing efficiency, improving safety, and enabling minimally invasive care.
This milestone represents a concrete embodiment of "new-quality productivity", showcasing the strong synergy between technological innovation and industrial progress in healthcare.
At the special event "First Equipment Empowering Enterprise Innovation", held during the CIFTIS 2025, Ms. Sun Hui, Director of Business Development and Group Business at WeMed Medical, signed a major medical robot leasing agreement with Beijing Robot Leasing Company.
At the Health Services Supply and Demand Matching Conference, Mr. He Wandao, Product Marketing Manager at WeMed Medical, delivered a keynote speech on the development journey and future trends of interventional robots. The audience included dozens of representatives from government, industry, academia, healthcare, and investment sectors.
WeMed Medical's Endovascular Robotic System, a globally leading product independently developed by the company, embodies the highest level of technological achievement in today's field of interventional surgery. The system is built on the innovative concept of Eye-Hand-Brain" synergy, seamlessly integrating image guidance, surgical operation, and intelligent decision-making through advanced smart technologies.
On the global innovation exchange platform at the CIFTIS 2025, WeMedMedical's interventional robot demonstrated that true medical technology innovation is not driven by hype, but grounded in clinical needs, guided by policy, and strengthened through ecosystem collaboration.
As more achievements-precisely designed and effectively implemented-continue to emerge, the integration of technological and industrial innovation will become increasingly robust and far-reaching.
